What's new in Interventional Cardiology

Welcome to Turning Point, a new podcast series brought to you by EuroIntervention — as part of our 20th anniversary celebration. 

What’s the safest approach when surgical options are off the table? This real-life case shows how complex coronary revascularsation and TAVI were performed in a single session, supported by Impella.

Explore the rationale behind the sequence, the device choices, and the outcome in a high-risk patient with...

Incomplete surgical LAA closure: how would you proceed?
Despite prior closure with an Atriclip during CABG, transoesophageal echocardiography reveals a persistent LAA gap in a high-risk patient with recurrent bleeding.
Explore the clinical details, imaging, and treatment dilemmas—then share your management approach!

A successful carotid artery stenting procedure is the result of multiple choices of devices and techniques including the vascular approach. Trans-radial approach is a feasible, safe and effective strategy both as a first-choice approach and as an alternative to the femoral route. Revisit the recently updated...

Managing ACS in a high-bleeding-risk patient is always a delicate balance. In this case, an 83-year-old with NSTEMI, advanced CKD, and a recent intracranial hemorrhage presented with a complex mid-to-distal LAD lesion. What would be your strategy?

Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...

Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...

Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among which is the...

The Andreas Grüntzig Ethica Award is traditionally given to those who have contributed in an extraordinary way to the PCR mission, that of serving the needs of patients by sharing knowledge, experience and practice in cardiovascular interventional medicine.

If you want to learn more about the specific challenges posed by the treatment and the risk-benefit balance of elective revascularisation procedures, don't wait any longer and read this brand-new chapter written by F. Ribichini and colleagues, available exclusively to subscribers.